Baking Enzymes Portfolio
Novonesis provides enzyme systems for industrial bakeries that improve dough handling, crumb softness, loaf volume, and shelf life while enabling clean-label formulations by replacing chemical emulsifiers and dough conditioners.
Overview
The baking enzyme portfolio includes amylases for anti-staling and crumb softness, lipases for dough strengthening and emulsification, xylanases for dough extensibility and water absorption, and proteases for gluten modification. These enzymes are classified as processing aids in most jurisdictions, meaning they need not be declared on the finished product label. Novonesis provides application-specific blends optimized for bread, buns, tortillas, cakes, and pastry.
Technical specifications
- Enzyme classes: amylases (anti-staling, crumb softness), lipases (dough strengthening, emulsification), xylanases (extensibility, water absorption), proteases (gluten modification)
- Product formats: application-specific enzyme blends for bread, buns, tortillas, cakes, pastry
- Labeling: processing aid classification — typically not declared on ingredient list
- Replaces: chemical emulsifiers (DATEM, SSL, CSL), dough conditioners, added vital wheat gluten in some applications
- Services: bakery application centers for customer trials and co-development
Technology readiness level
TRL 9 — commercially established enzyme systems used by industrial bakeries worldwide.
About Novonesis
Novonesis is a global biosolutions company formed in 2024 through the combination of Chr. Hansen and Novozymes. The organization specializes in microbiology and industrial fermentation, developing a diverse range of biosolutions used across more than 30 industries, including food and nutrition, agriculture, household care, and energy. By leveraging science and the power of biology, Novonesis creates innovations that help customers reduce their reliance on fossil-based resources, chemicals, energy, and water. The company operates with a purpose to better the world with biology, focusing on sustainable production and consumption patterns.
For customers and partners, Novonesis provides tailored solutions supported by deep scientific expertise and flexible, global production capabilities. The company serves as a strategic partner, enabling clients to achieve higher yields, improve resource efficiency, and differentiate their own products in the marketplace. With over 11,000 employees worldwide, Novonesis utilizes data-driven insights and AI to accelerate its research and development, ensuring it remains at the forefront of the biosolutions sector and continues to drive long-term value for stakeholders across the globe.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.